Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon

Medtronic provides update on tender offer

Medtronic announced it had tendered approximately $5.8 billion in aggregate principal of outstanding debt securities as of 5:00 p.m. Eastern time on April 13, the early deadline for a previously announced tender offer.

Mean price of insulin increases nearly 200% from 2002 to 2013

From 2002 to 2013, the mean price of insulin increased 197 percent, from $4.34 per milliliter to $12.92 per milliliter, according to a survey of more than 27,000 people treated for diabetes.

CMS proposes ban on Theranos founder and president

The Centers for Medicare and Medicaid Services (CMS) have proposed banning Theranos founder Elizabeth Holmes and president Sunny Balwani from owning or running a blood-testing lab for at least two years.

Medtronic releases statement defending Covidien deal in wake of proposed tax regulations

After the U.S. Department of Treasury issued temporary and proposed regulations on tax inversions and other related topics, Medtronic announced in a news release on April 6 that the regulations “do not have a material financial impact on any transaction undertaken by the company.”

Medtronic announces cash tender offer for up to $2.75 billion in outstanding debt

Medtronic announced a cash tender offer on March 31 for up to $2.75 billion in aggregate purchase price for outstanding debt issued by Medtronic, Inc. and Covidien International Finance S.A., two of the company’s wholly-owned subsidiaries.

Edwards Lifesciences announces new member to its board of directors

Edwards Lifesciences Corp. announced that Steven R. Loranger had been appointed to its board of directors.

Report: Global market for peripheral vascular interventions will reach $3.4B by 2022

By 2022, the global market for lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons, carotid stents, renal stents and other peripheral vascular interventions will increase to $3.4 billion, up from $2.1 billion last year.

Florida businessman sentenced to 14 years in jail for healthcare fraud and money laundering

A Florida businessman was sentenced to more than 14 years in prison for his role in a healthcare fraud and money laundering scheme, according to a Department of Justice (DOJ) news release.

Displaying 1225 - 1232 of 1706

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.